Liquid biopsy innovator Nimble Genomics “will transform the diagnosis and stratification of cancers, including brain cancers,” said co-founder Henno Martin, opening the company’s pitch at the Cancer Tech Accelerator Demo Day held on 24 October by European intellectual property firm HGF.
“Around 1,400 patients are diagnosed with low-grade glioma every year in the UK. Often, the diagnosis is delayed due to...